The Prevalence of Hand Joint Hypermobility and Its Relationship With Grip Strength Among University Students.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No Interventions.
- Who it may be relevant to
- Registry conditions: Hand Joint Hypermobility, Grip Strength. Basic parameters: 18 years — 24 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Prevalence of Hand Joint Hypermobility and Its Relationship With Grip Strength Among University Students
Overview
This cross-sectional study investigated the prevalence of hand joint hypermobility among 400 university students and its relationship with hand grip strength. MCP joint mobility was assessed using a universal goniometer, and grip strength was measured with a hand dynamometer. Participants were categorized into mild, moderate, and severe hypermobility groups.
Detailed description
Objective: This study aims to determine the prevalence of hand joint hypermobility among university students and examine its association with hand grip strength. Specifically, it seeks to compare grip strength between students with and without hypermobility and explore potential implications for educational activities such as writing and studying.
Design: A descriptive cross-sectional study was conducted among 400 students. Settings: 400 students recruited from both public and private universities. Participants: Students were assessed at the metacarpophalangeal (MCP) joints using a universal goniometer, while hand grip strength was measured with an adjustable hand dynamometer. Based on MCP range of motion, participants were categorized into three groups: mild, moderate, and severe hypermobility.
Intervention: Not Applicable. Main outcome measures: Metacarpophalangeal (MCP) joint hypermobility was measured using a universal goniometer, and grip strength was assessed using a hand dynamometer.
Interventions
- Other No Interventions
NO INTERVENTION
Primary outcome measures
- Metacarpophalangeal (MCP) joint hypermobility was measured using a universal goniometer, [Time frame: 1 JAN 2026 TO 30 JAN 2026]
- grip strength was assessed using a hand dynamometer [Time frame: once]
Eligibility criteria
Inclusion criteria
- Participants were eligible if they were undergraduate university students enrolled in the 2023/2024 academic year, male or female, aged between 18 and 22 years, and had no previously diagnosed systemic conditions associated with hypermobility (e.g., Ehlers-Danlos syndrome or generalized hypermobility syndrome).
Exclusion criteria
- Participants were excluded if they had a previously diagnosed systemic condition associated with hypermobility, reported musculoskeletal injuries or conditions affecting joint mobility or grip strength at the time of assessment, were unable or unwilling to provide informed consent, had any neurological or chronic disorders that could influence muscle strength or joint range of motion or were outside the specified age range (18-22 years).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Egypt · 1 center
- Horus University — Damietta
Publications
- Remvig L, Jensen DV, Ward RC. Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol. 2007 Apr;34(4):804-9. Epub 2007 Jan 15. PMID 17407233
Identifiers
NCT: NCT07363564 · (Approval No: P.T.REC/012/0047